在肺癌中EBV病毒和细胞代谢的相互作用
1Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.
Journal of cellular and molecular medicine
|November 27, 2024
概括
爱斯坦-巴尔病毒操纵肺癌细胞代谢,促进瘤生长和免疫逃避. 针对这些病毒代谢变化为爱斯坦-巴尔病毒相关的肺癌提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 代谢研究研究 代谢研究
背景情况:
- 爱斯坦-巴尔病毒 (EBV) 与各种癌症有关.
- 埃博病毒感染可以影响宿主细胞代谢,可能导致肺癌的瘤发生.
- 了解EBV的代谢重编程对于开发向疗法至关重要.
研究的目的:
- 审查爱斯坦-巴尔病毒和肺癌中细胞代谢之间的复杂关系.
- 要突出EBV重编程细胞代谢的机制.
- 讨论对新型治疗策略的影响.
主要方法:
- 对研究EBV,肺癌和细胞代谢的文献综述.
- 分析病毒蛋白 (LMP1,LMP2A) 和它们的代谢标.
- 检查代谢途径,包括糖解,谷氨酸溶解和脂质代谢.
主要成果:
- 像LMP1和LMP2A这样的EBV蛋白质显著改变宿主细胞代谢.
- 代谢重编程支持瘤微环境中的病毒复制和免疫逃避.
- 由EBV引起的代谢脆弱性被确定为潜在的治疗点.
结论:
- 爱斯坦-巴尔病毒积极重塑肺癌细胞的新陈代谢.
- 针对病毒诱导的代谢途径为EBV相关的肺癌提供了一个有希望的治疗途径.
- 对这些相互作用的进一步研究可以导致创新的治疗策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Electron Transport Chain: Complex I and II
11.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


